Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
502-04-007 ISMRM Abstract

Prediction of Sentinel Lymph Node Metastasis in Breast Cancer Using Intratumoral T2 Mapping and Peritumoral Edema

Accepted
Tianwen Xie 1,2, Yan Huang1,2, Caixia Fu3, Tom Hilbert4,5,6, Tobi Kober7, Weijun Peng1,2, Yajia Gu1,2
1Radiology, Fudan University Shanghai Cancer Center, Shanghai, China
2Oncology, Shanghai Medical College, Fudan University, Shanghai, China
3MR Application Development, Siemens Shenzhen Magnetic Resonance Ltd., Shenzhen, China
4Swiss Innovation Hub, Siemens Healthineers International AG, Lausanne, Switzerland
5LTS5, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
6Department of Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
7Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany
Presenting Author: Tianwen Xie

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Byon JH, Park YV, Yoon JH, Moon HJ, Kim EK, Kim MJ, You JK. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era. Radiology. 2021 Jul;300(1):46-54. doi: 10.1148/radiol.2021202683. Epub 2021 Apr 27. PMID: 33904772. [doi] [pmid]
2. Uematsu T. Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema. Breast Cancer. 2015 Jan;22(1):66-70. doi: 10.1007/s12282-014-0572-9. Epub 2014 Oct 22. PMID: 25336185. [doi] [pmid]
3. Liu L, Yin B, Shek K, Geng D, Lu Y, Wen J, Kuai X, Peng W. Role of quantitative analysis of T2 relaxation time in differentiating benign from malignant breast lesions. J Int Med Res. 2018 May;46(5):1928-1935. doi: 10.1177/0300060517721071. Epub 2018 Mar 20. PMID: 29557239; PMCID: PMC5991255. [doi] [pmid]
4. Hilbert T, Sumpf TJ, Weiland E, Frahm J, Thiran JP, Meuli R, Kober T, Krueger G. Accelerated T2 mapping combining parallel MRI and model-based reconstruction: GRAPPATINI. J Magn Reson Imaging. 2018 Aug;48(2):359-368. doi: 10.1002/jmri.25972. Epub 2018 Feb 15. PMID: 29446508. [doi] [pmid]
5. Block KT, Uecker M, Frahm J. Model-based iterative reconstruction for radial fast spin-echo MRI. IEEE Trans Med Imaging. 2009 Nov;28(11):1759-69. doi: 10.1109/TMI.2009.2023119. Epub 2009 Jun 5. PMID: 19502124. [doi] [pmid]
6. Tucker NS, Cyr AE, Ademuyiwa FO, Tabchy A, George K, Sharma PK, Jin LX, Sanati S, Aft R, Gao F, Margenthaler JA, Gillanders WE. Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer. Ann Surg. 2016 Dec;264(6):1098-1102. doi: 10.1097/SLA.0000000000001549. PMID: 26779976; PMCID: PMC4947031. [doi] [pmid]
7. Hwang SO, Lee SW, Kim HJ, Kim WW, Park HY, Jung JH. The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer. J Breast Cancer. 2013 Sep;16(3):315-21. doi: 10.4048/jbc.2013.16.3.315. Epub 2013 Sep 30. PMID: 24155761; PMCID: PMC3800728. [doi] [pmid]
8. Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165. PMID: 18541009; PMCID: PMC2430574. [doi] [pmid]

Cite this abstract